Literature DB >> 33682638

Are we using the right method to estimate the number of COVID-19 cases?

José Moreno-Montoya1, Sergio A Valencia1, Silvia Marcela Ballesteros1, Pedro Barrera-López1, Erika D Pérez-Riveros1.   

Abstract

The great concern stemming from the current COVID-19 pandemic has been a challenge for governments and international organizations around the world. Likewise, the diagnosis has played an important role in the prioritization processes, in particular, for the identification and follow-up of cases. In this context, PCR and serological tests have become the international standard; however, some limitations, as well as the scope of these techniques, must be understood in terms of population numbers. This comment seeks to clarify the interpretation of the results of these tests from a public health perspective.

Entities:  

Keywords:  COVID-19; Diagnosis; Polymerase Chain Reaction; Serological test

Mesh:

Year:  2021        PMID: 33682638      PMCID: PMC8547842          DOI: 10.1080/20477724.2021.1897242

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  5 in total

1.  Reconstruction of the full transmission dynamics of COVID-19 in Wuhan.

Authors:  Xingjie Hao; Shanshan Cheng; Degang Wu; Tangchun Wu; Xihong Lin; Chaolong Wang
Journal:  Nature       Date:  2020-07-16       Impact factor: 49.962

2.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.

Authors:  Marina Pollán; Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Jesús Oteo; Miguel A Hernán; Mayte Pérez-Olmeda; Jose L Sanmartín; Aurora Fernández-García; Israel Cruz; Nerea Fernández de Larrea; Marta Molina; Francisco Rodríguez-Cabrera; Mariano Martín; Paloma Merino-Amador; Jose León Paniagua; Juan F Muñoz-Montalvo; Faustino Blanco; Raquel Yotti
Journal:  Lancet       Date:  2020-07-06       Impact factor: 79.321

3.  Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.

Authors:  Mayara Lisboa Bastos; Gamuchirai Tavaziva; Syed Kunal Abidi; Jonathon R Campbell; Louis-Patrick Haraoui; James C Johnston; Zhiyi Lan; Stephanie Law; Emily MacLean; Anete Trajman; Dick Menzies; Andrea Benedetti; Faiz Ahmad Khan
Journal:  BMJ       Date:  2020-07-01

4.  Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19.

Authors:  Poramed Winichakoon; Romanee Chaiwarith; Chalerm Liwsrisakun; Parichat Salee; Aree Goonna; Atikun Limsukon; Quanhathai Kaewpoowat
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

5.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.

Authors:  Silvia Stringhini; Ania Wisniak; Giovanni Piumatti; Andrew S Azman; Stephen A Lauer; Hélène Baysson; David De Ridder; Dusan Petrovic; Stephanie Schrempft; Kailing Marcus; Sabine Yerly; Isabelle Arm Vernez; Olivia Keiser; Samia Hurst; Klara M Posfay-Barbe; Didier Trono; Didier Pittet; Laurent Gétaz; François Chappuis; Isabella Eckerle; Nicolas Vuilleumier; Benjamin Meyer; Antoine Flahault; Laurent Kaiser; Idris Guessous
Journal:  Lancet       Date:  2020-06-11       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.